sunday 23 sEpTEMbEr - ehmtic 2012
sunday 23 sEpTEMbEr - ehmtic 2012
sunday 23 sEpTEMbEr - ehmtic 2012
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
EHMTIC20I2<br />
European Headache and Migraine Trust International Congress<br />
frIday 21 <strong>sEpTEMbEr</strong><br />
EHMTIC/Iasp JoInT sEssIon<br />
SESSION 2<br />
Chairpersons: R Burstein (USA), D Mitsikostas (Greece)<br />
09.00-09.45 Relevance of Pain Imaging Studies for Understanding Migraine<br />
I Tracey<br />
Nuffield Professor, Anaesthetic Science and Director, Oxford Centre for FMRI of Brain, UK<br />
09.45-10.30 Analgesic drug development: Time to break the mould<br />
C Woolf, MB, BCh, PhD<br />
F.M. Kirby Neurobiology Center, Boston Children’s Hospital and Department of Neurobiology,<br />
Harvard Medical School, Boston MA, USA<br />
10.30-12.00 posTEr sEssIon a<br />
SESSION 3<br />
Genes and Environment: Genetics, Epidemiology and Paediatric Headaches<br />
Chairpersons: G Terwindt (Netherlands), V Guidetti (Italy), Z Katsarava (Germany)<br />
Poster numbers P1-P35, LB02, LB13<br />
including ongoing refreshments<br />
10.30-11.10 Poster viewing in Exhibition Area<br />
11.10-11.20 BREAK<br />
12.00-12.30 LUNCH BREAK<br />
11.20-12.00 Poster discussion in Kings Suite<br />
12.30-14.30 saTEllITE syMposIuM<br />
BOTOX ® IN CHRONIC MIGRAINE: SHARING EXPERIENCES, IMPROVING OUTCOMES<br />
Chairperson: Hans-Christoph Diener (Germany)<br />
Sponsored by Allergan Inc<br />
12.30-12.40 Welcome and introduction<br />
Chairman: Hans-Christoph Diener (Germany)<br />
12.40-13.05 From guidelines to clinical practice: identification and diagnosis of the chronic<br />
migraine patience<br />
Hans-Christoph Diener (Germany)<br />
13.05-13.35 Cost-effectiveness of BOTOX ® in chronic migraine: real-life experience<br />
John Rothrock (USA)<br />
13.35-14.05 Managing the chronic migraine patient on BOTOX ® : lessons from clinical practice<br />
Reto Agosti (Switzerland)<br />
14.05-14.25 Panel discussion<br />
27